United States· US:27241-170_4f6891be-49a9-4884-a1ce-35e148c7c156
Doxepin hydrochloride
A doxepin product containing doxepin hydrochloride, registered in United States by Ajanta Pharma USA Inc.. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Doxepin is registered in 2 of 19 countries.
Countries holding a registration under ATC D04AX01 (doxepin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Doxepin · ATC D04AX01
2 / 19 countries
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Doxepin hydrochloride
- Manufacturer
- Ajanta Pharma USA Inc.
- Country
- United States (US)
- ATC code
- D04AX01
- ATC class
- Doxepin
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 2
- ndc112724117001100 CAPSULE in 1 BOTTLE (27241-170-01)
- ndc1127241170101000 CAPSULE in 1 BOTTLE (27241-170-10)
Regulatory notes
Interactions
591 interactions on record for doxepin.
Graded by severity as the source publishes them — 127 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Doxepin · interactions on record
591 records
- 127 severe
- 448 moderate
- 16 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Doxepin in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyAponal AmpullenCheplapharm Arzneimittel Gmbh
- FinlandDoxalOrion Corporation
- BelgiumSinequan 25 mgPfizer
- NorwayDoxepin tevaTeva
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Germany · Aponal Ampullen, Aponal Tropfen
- France · Quitaxon
- United Kingdom (Northern Ireland) · Doxepin Zentiva Pharma, Xepin
- Poland · Doxepin Teva
- Romania · Doxepin Terapia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f0c02dc8-b2c4-4bad-a0e4-ba492e5ef299 GET /v1/drugs/f0c02dc8-b2c4-4bad-a0e4-ba492e5ef299?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "3U9A0FE9N5",
"rxcui": "203179",
"inchikey": null,
"display_name": "DOXEPIN HYDROCHLORIDE",
"substance_type": "mixture",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 3
},
"spl_meta": {
"89ed6385-cf6a-458e-81ea-c7f3fead41c5": {
"match": "brand_token",
"title": "DOXEPIN HYDROCHLORIDE CAPSULE [HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.]",
"spl_version": "2",
"published_date": "2026-05-13"
}
},
"productid": "27241-170_4f6891be-49a9-4884-a1ce-35e148c7c156",
"productndc": "27241-170",
"dosage_form": "CAPSULE",
"orange_book": {
"appl_no": "212624",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 10MG BASE",
"product_no": "001",
"approval_date": "Sep 13, 2019"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 25MG BASE",
"product_no": "002",
"approval_date": "Sep 13, 2019"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 50MG BASE",
"product_no": "003",
"approval_date": "Sep 13, 2019"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 75MG BASE",
"product_no": "004",
"approval_date": "Sep 13, 2019"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 100MG BASE",
"product_no": "005",
"approval_date": "Sep 13, 2019"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "DOXEPIN HYDROCHLORIDE",
"proprietary_name": "Doxepin hydrochloride",
"active_ingred_unit": "mg/1",
"application_number": "ANDA212624",
"marketing_category": "ANDA",
"nonproprietary_name": "Doxepin hydrochloride",
"start_marketing_date": "20191220",
"active_numerator_strength": "75"
}See everything about doxepin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.